QRS-T angle : is it a specific parameter associated with sudden cardiac death in type 2 diabetes? Results from the SURDIAGENE and the Mini-Finland prospective cohorts
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature..
AIMS/HYPOTHESIS: Type 2 diabetes is associated with a high risk of sudden cardiac death (SCD), but the risk of dying from another cause (non-SCD) is proportionally even higher. The aim of the study was to identify easily available ECG-derived features associated with SCD, while considering the competing risk of dying from non-SCD causes.
METHODS: In the SURDIAGENE (Survie, Diabete de type 2 et Genetique) French prospective cohort of individuals with type 2 diabetes, 15 baseline ECG parameters were interpreted among 1362 participants (mean age 65 years; HbA1c 62±17 mmol/mol [7.8±1.5%]; 58% male). Competing risk models assessed the prognostic value of clinical and ECG parameters for SCD after adjusting for age, sex, history of myocardial infarction, N-terminal pro b-type natriuretic peptide (NT-proBNP), HbA1c and eGFR. The prospective Mini-Finland cohort study was used to externally validate our findings.
RESULTS: During median follow-up of 7.4 years, 494 deaths occurred including 94 SCDs. After adjustment, frontal QRS-T angle ≥90° (sub-distribution HR [sHR] 1.68 [95% CI 1.04, 2.69], p=0.032) and NT-proBNP level (sHR 1.26 [95% CI 1.06, 1.50] per 1 log, p=0.009) were significantly associated with a higher risk of SCD. Nevertheless, frontal QRS-T angle was the only marker not to be associated with causes of death other than SCD (sHR 1.08 [95% CI 0.84, 1.39], p=0.553 ). These findings were replicated in the Mini-Finland study subset of participants with diabetes (sHR 2.22 [95% CI 1.05, 4.71], p=0.04 for SCD and no association for other causes of death).
CONCLUSIONS/INTERPRETATION: QRS-T angle was specifically associated with SCD risk and not with other causes of death, opening an avenue for refining SCD risk stratification in individuals with type 2 diabetes.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:67 |
---|---|
Enthalten in: |
Diabetologia - 67(2024), 4 vom: 24. März, Seite 641-649 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Garcia, Rodrigue [VerfasserIn] |
---|
Links: |
---|
Themen: |
Electrocardiogram |
---|
Anmerkungen: |
Date Completed 01.03.2024 Date Revised 01.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s00125-023-06074-4 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367580764 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367580764 | ||
003 | DE-627 | ||
005 | 20240301232404.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240125s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s00125-023-06074-4 |2 doi | |
028 | 5 | 2 | |a pubmed24n1313.xml |
035 | |a (DE-627)NLM367580764 | ||
035 | |a (NLM)38267653 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Garcia, Rodrigue |e verfasserin |4 aut | |
245 | 1 | 0 | |a QRS-T angle |b is it a specific parameter associated with sudden cardiac death in type 2 diabetes? Results from the SURDIAGENE and the Mini-Finland prospective cohorts |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.03.2024 | ||
500 | |a Date Revised 01.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. | ||
520 | |a AIMS/HYPOTHESIS: Type 2 diabetes is associated with a high risk of sudden cardiac death (SCD), but the risk of dying from another cause (non-SCD) is proportionally even higher. The aim of the study was to identify easily available ECG-derived features associated with SCD, while considering the competing risk of dying from non-SCD causes | ||
520 | |a METHODS: In the SURDIAGENE (Survie, Diabete de type 2 et Genetique) French prospective cohort of individuals with type 2 diabetes, 15 baseline ECG parameters were interpreted among 1362 participants (mean age 65 years; HbA1c 62±17 mmol/mol [7.8±1.5%]; 58% male). Competing risk models assessed the prognostic value of clinical and ECG parameters for SCD after adjusting for age, sex, history of myocardial infarction, N-terminal pro b-type natriuretic peptide (NT-proBNP), HbA1c and eGFR. The prospective Mini-Finland cohort study was used to externally validate our findings | ||
520 | |a RESULTS: During median follow-up of 7.4 years, 494 deaths occurred including 94 SCDs. After adjustment, frontal QRS-T angle ≥90° (sub-distribution HR [sHR] 1.68 [95% CI 1.04, 2.69], p=0.032) and NT-proBNP level (sHR 1.26 [95% CI 1.06, 1.50] per 1 log, p=0.009) were significantly associated with a higher risk of SCD. Nevertheless, frontal QRS-T angle was the only marker not to be associated with causes of death other than SCD (sHR 1.08 [95% CI 0.84, 1.39], p=0.553 ). These findings were replicated in the Mini-Finland study subset of participants with diabetes (sHR 2.22 [95% CI 1.05, 4.71], p=0.04 for SCD and no association for other causes of death) | ||
520 | |a CONCLUSIONS/INTERPRETATION: QRS-T angle was specifically associated with SCD risk and not with other causes of death, opening an avenue for refining SCD risk stratification in individuals with type 2 diabetes | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Electrocardiogram | |
650 | 4 | |a Mortality | |
650 | 4 | |a Sudden cardiac death | |
650 | 4 | |a Type 2 diabetes | |
700 | 1 | |a Schröder, Linda C |e verfasserin |4 aut | |
700 | 1 | |a Tavernier, Marine |e verfasserin |4 aut | |
700 | 1 | |a Gand, Elise |e verfasserin |4 aut | |
700 | 1 | |a de Keizer, Joe |e verfasserin |4 aut | |
700 | 1 | |a Holkeri, Arttu |e verfasserin |4 aut | |
700 | 1 | |a Eranti, Antti |e verfasserin |4 aut | |
700 | 1 | |a Bidegain, Nicolas |e verfasserin |4 aut | |
700 | 1 | |a Alos, Benjamin |e verfasserin |4 aut | |
700 | 1 | |a Junttila, Juhani |e verfasserin |4 aut | |
700 | 1 | |a Knekt, Paul |e verfasserin |4 aut | |
700 | 1 | |a Roumegou, Pierre |e verfasserin |4 aut | |
700 | 1 | |a Gamet, Alexandre |e verfasserin |4 aut | |
700 | 1 | |a Bouleti, Claire |e verfasserin |4 aut | |
700 | 1 | |a Degand, Bruno |e verfasserin |4 aut | |
700 | 1 | |a Ragot, Stéphanie |e verfasserin |4 aut | |
700 | 1 | |a Hadjadj, Samy |e verfasserin |4 aut | |
700 | 1 | |a Aro, Aapo L |e verfasserin |4 aut | |
700 | 1 | |a Saulnier, Pierre-Jean |e verfasserin |4 aut | |
700 | 0 | |a SURDIAGENE and the Mini-Finland study groups |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Diabetologia |d 1966 |g 67(2024), 4 vom: 24. März, Seite 641-649 |w (DE-627)NLM000017035 |x 1432-0428 |7 nnns |
773 | 1 | 8 | |g volume:67 |g year:2024 |g number:4 |g day:24 |g month:03 |g pages:641-649 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00125-023-06074-4 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 67 |j 2024 |e 4 |b 24 |c 03 |h 641-649 |